GSK and Adolor – unwanted

without comments


Pain, vomiting, accumulated gas, abdominal distention, bloated, delayed flatus, impaired GI motility, delayed defecation, nausea…

Postoperative ileus can fill your patients with unwanted symptoms.
-Postoperative ileus (POI) cannot be reliably predicted before bowel resection surgery
-POI can be a cause for prolonged hospitalization and for increased readmission rates

Is there more you can do to manage your patients’ POI?

Brand name: n/a
Generic name/category: disease awareness
Company: GlaxoSmithKline and Adolor
Country/Market: USA, North America
Indication(s)/use: GI impairment and discomfort
Target: Healthcare Professionals (HCP)
Tagline: n/a
Medium: Print ad
Size/duration: Single-page
Publication/Aired: Surgery News – December 2009

Click here for the full-sized ad and details in the gallery

This ad and thousands more can be seen on the AdPharm gallery, the largest keyword searchable online pharmaceutical advertising gallery.

Written by AdPharm

February 8th, 2010 at 1:08 pm

6 views